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The N-terminus of the human immunodeficiency virus (HIV) pathogenicity factor Nef associates with a protein complex (NAKC for Nef-
associated kinase complex) that contains at least two kinases: the tyrosine kinase Lck and a serine kinase activity which was found to
phosphorylate Lck and the Nef N-terminus. Here we show that this serine kinase activity is mediated by members of the novel Protein Kinase C
(nPKC) subfamily, PKCδ and θ. Association with the Nef N-terminus was sufficient to activate PKC leading to phosphorylation of Nef in vitro on
a conserved serine residue at position 6. Mutation of serine 6 or coexpression of a transdominant negative PKC mutant significantly reduced Nef-
stimulated HIV transcription and replication in resting PBMC. When analyzing the molecular mechanisms, we found that mutating serine 6
moderately affected myristoylation of Nef and its association with Pak2 activity, whereas CD4 downmodulation was not inhibited. More
interestingly, this mutation abolished the typical perinuclear localization of Nef in T cells. We conclude that the activation of nPKCs by Nef is
required to increase viral replication/infectivity and direct the subcellular localization of Nef.
© 2007 Elsevier Inc. All rights reserved.Keywords: Nef; Phosphorylation; PKC; Transcription; Subcellular localizationIntroduction
The HIV nef gene plays a key role in disease progression;
however, its molecular function is poorly understood. To date, at
least three effects of Nef have been described, namely alteration
of surface exposure of multiple host cell receptors (Arold and
Baur, 2001; Garcia and Miller, 1991; Michel et al., 2005, 2006;
Roeth and Collins, 2006; Schwartz et al., 1996; Stumptner-
Cuvelette et al., 2003), modulation of T cell activation pathways
(Baur et al., 1994; Fackler and Baur, 2002) and increase of viral
replication as well as virion infectivity (Aiken and Trono, 1995;⁎ Corresponding authors. A. Baur is to be contacted at fax: +1 305 243 7211.
O.T. Fackler, fax: +49 6221 565003.
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exerts some effects through interaction with T cell signaling
proteins; however, it is not clear how the multiple Nef-
interacting molecules orchestrate these different effects and
whether they are interconnected. Thus, the functional character-
ization of Nef-associated cellular factors is critical to understand
Nef's role in HIV pathogenesis.
Nef-associated proteins can be roughly divided into three
groups or complexes. One group of proteins binds to the
conserved central part (core) of Nef, including at least the Pak2
kinase (Renkema et al., 1999), the Rac GTPase, the Vav protein
(Fackler et al., 1999) and the DOCK2-ELMO1 complex
(Janardhan et al., 2004). Active Pak2 is recruited upon assembly
of this complex in membrane microdomains mediating
transcriptional activation and cytoskeleton rearrangements
(Krautkramer et al., 2004; Renkema et al., 2002; Pulkkinen
46 D. Wolf et al. / Virology 370 (2008) 45–54et al., 2004). In addition, this event correlated with augmented
virion infectivity, particle production and modulation of TCR
stimulatory contacts of T lymphocytes (Fackler et al., 1999;
Haller et al., 2006; Lu et al., 1996; Wiskerchen and Cheng-
Mayer, 1996). The Nef core was also shown to interact with the
SH3 domain of the tyrosine kinases Lck, Lyn and Hck through a
proline rich motif (Collette et al., 1996; Saksela et al., 1995).
Furthermore, the TCR zeta chain associates with the core
domain (Xu et al., 1999).
The C-terminal part of Nef interacts with another set of
proteins, which mediates the internalization of surface receptors
as well as Nef from the plasma membrane via the clathrin-
coated pits. This process is mediated through interaction of LL
and ED motifs in the C-terminus with adaptor protein
complexes (AP-1/2) (Bresnahan et al., 1998; Greenberg et al.,
1998; Le Gall et al., 1998) and the vacuolar ATPase V1H
(Geyer et al., 2002; Lu et al., 1998). The presence of these
motifs also correlates with increased infectivity and replication
of HIV and SIV particles (Craig et al., 1998; Lu et al., 1998;
Mandic et al., 2001).
Associating with the N-terminus of Nef another protein
complex was identified (NAKC for Nef-associated kinase
complex) containing at least two kinases, namely Lck and a
second serine kinase different from Pak2. This serine kinase
(originally termed SKII) phosphorylated the Nef N-terminus as
well as Lck (Baur et al., 1997; Witte et al., 2004) in vitro.
Association of the NAKC did not affect downregulation of CD4
but was required for optimal viral replication in primary T cells
(Baur et al., 1997). In the study presented here, we have
identified the second serine kinase as the novel PKC (nPKC)
family members PKCθ and δ both of which phosphorylated Nef
in vitro on a conserved serine residue at position 6. Both the
nPKCs as well as serine 6 were relevant for positive Nef effects
on viral transcription and replication. Functional analyses
demonstrated that serine 6 was required for optimal myristoyla-
tion and perinuclear targeting of Nef. Collectively our data
imply that nPKCs play a critical role in Nef-mediated effects on
HIV replication/infectivity and subcellular targeting.
Results
Phosphorylation of a PKC consensus motif at the Nef
N-terminus
After immunoprecipitation from T cells, short N-terminal
fragments of SIV/HIV-Nefs are phosphorylated on a serine
residue by an associated kinase activity (termed SKII), which
binds to Nef in the context of the NAKC (Fig. 1A). This was
demonstrated by in vitro kinase assays (IVKA) for N-terminal
Nef fragments as well as full length Nef proteins (Baur et al.,
1997). In order to identify the phosphorylation site of SKII,
serine residues 6, 9 or 14 of Nef (Fig. 1C) were mutated to
alanine. The mutations were introduced into a 35 amino acid N-
terminal fragment of Nef, fused to a truncated CD8 molecule
(CN.35) as described previously (Baur et al., 1997). Nef
phosphorylation was determined by in vitro kinase assay
(IVKA) after transient transfection into COS cells and anti-CD8(Nef) immunoprecipitation. Mutation of serine residue 6 but not
9 or 14 abolished phosphorylation of CN.35 (Fig. 1B, upper
panel). The basic amino acids flanking serine residue 6 sug-
gested a conserved recognition sequence for PKC (Fig. 1C).
Therefore, the IVKAs with CN.35 were repeated in the presence
of the PKC inhibitors H7 and Staurosporin. As shown in Fig.
1D, upper left panel, both compounds inhibited phosphoryla-
tion of CN.35. To confirm these findings, the characteristic
basic residues of the PKC recognition motif at position 7 and 8
were mutated to alanine and proline. The mutations almost
completely abolished phosphorylation of CN.35 in vitro
(Fig. 1D, lanes 4 and 5). Taken together these results suggested
that SKII was a PKC isoenzyme that phosphorylates the Nef
N-terminus in a serine 6 dependent manner.
The N-terminus of HIV/SIV-Nef associates with PKCδ and θ
In order to determine which PKC-isoenzyme phosphorylated
Nef, different family members (α, β, γ, δ, ε, ζ, θ) were
coexpressed in COS cells with CN.35 and an IVKA was
performed. As shown in Fig. 1E, basal levels of CN.35
phosphorylation markedly increased in the presence of PKCδ
and θ. Moreover, both PKC isoforms coprecipitated with CN.35
as indicated by the presence of autophosphorylated PKC in the
IVKA reaction. Expression of the various PKC isoforms in
COS cells was verified in independent experiments (Fig. 1F).
Identical results were obtained for other N-terminal Nef
fragments including CN.49 and CN.94 (data not shown). This
result implied that SKII was either PKCδ or θ. Despite
numerous different experimental approaches including one
with siRNA, we never observed a significant difference
between the interactions of Nef with PKCδ or θ (see also
below and data not shown). This may be due to the high degree
of homology between both members of the nPKC subfamily.
To confirm that nPKCs also phosphorylated full length and
untagged Nef, an in vitro phosphorylation experiment was
performed with immunoprecipitated HIVand SIV Nef proteins.
As shown in Fig. 1G, coexpression of PKCδ increased
phosphorylation of both Nef proteins. Since we used full length
Nef, the association with Pak2 was also revealed (Fig. 1G, p62).
Pak2 activity was unaffected by PKCδ overexpression,
confirming that phosphorylation of Nef and Nef's association
with active Pak2 are independent events.
Next, we analyzed whether the Nef N-terminus was the only
protein interaction surface that associated with nPKCs. Like in a
previous study (Wolf et al., 2001), we used a series of CD8-Nef
deletion mutants to map potential other binding sites. Upon
coexpression of these mutants with PKCθ, (Fig. 2A) or PKCδ
(data not shown) in COS cells we found that besides the full
length protein and the N-terminus, the C-terminus associated
with PKC (Fig. 2A). Interestingly this binding pattern resembled
that of PI3K and Eed (Witte et al., 2004; Wolf et al., 2001).
Mutation of serine 6 to alanine did not affect binding of PKC to
full length Nef, whereas replacing serine 6 with a negatively
charged glutamic acid residue greatly reduced association with
PKC (Fig. 2B). The latter was likely due to the lack of
myristoylation of this mutant as shown below (see Fig. 6).
Fig. 1. A consensus sequence at the N-terminus of Nef is phosphorylated by PKCδ and θ. (A) Schematic representation of the Nef-associated kinase complex
(NAKC) as described previously (Baur et al., 1997). Serine kinase activity II (SKII). (B) SKII phosphorylates serine 6. Upper panel: In vitro kinase assay (IVKA)
after immunoprecipitation of CN.35 and CN.35 mutants, encoding an alanine instead of serine 6, 9, or 14 (S6A, S9A, S14A) from transiently transfected COS cells.
CN.35 (CN for CD8-Nef) represents a fusion protein between the extracellular and transmembrane domain of CD8 and the N-terminal 35 amino acids of Nef (Baur et
al., 1994). Lower panel: Western blot of NC-filter shown in upper panel using an anti-Nef polyclonal rabbit serum to verify comparable expression of all constructs.
(C) N-terminal Nef sequence of HIV-1SF2 showing serine residues 6, 9 and 14 in bold letters and a putative PKC recognition sequence (box). (D) PKC inhibitors
block phosphorylation of serine 6. IVKAs with CN.35 (lanes 1–3) in the presence of H7 or staurosporine (St.) and with a CN.35 mutant encoding an alanine instead
of lysin 7 and a proline instead of arginine 8 (KR/AP; lane 5). The experimental procedure was the same as described in panel B. Lower panels: Western blot of NC-
filter shown in upper panels using the same anti-Nef antibody as in panel B. (E) The N-terminus of HIV-Nef associates with PKCδ and θ. IVKAs after
immunoprecipitation of CN.49 from transiently transfected COS cells. The CN-fusion protein was cotransfected with different PKC-isoenzymes (α, β, γ, δ, ε, ζ, θ)
and an unrelated serine kinase (Mos). (F) Expression control by Western blot of the HA-tagged PKC isoenzymes used in panel E. The respective kinases were
transiently transfected into COS cells. (G) In vitro kinase assay after immunoprecipitation of full-length HIV-1/SIV Nef proteins from COS cells. The Nef-proteins
were cotransfected with PKCδ (lanes 2 and 4) or mock DNA (lanes 1 and 3). Lower panel shows the Western Blot of NC-filter shown in the upper panel using
antibodies against HIV and SIV-Nef.
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Our results also suggested that the association with Nef
activated PKC activity (Fig. 1E). In order to confirm this
assumption, myeline basic protein (MBP) was added as a
substrate to IVKAs of PKCδ and phosphorylation of MBP with
32P was measured. First, endogenous PKCδ was immunopre-
cipitated from Nef-transfected COS cells, demonstrating an
increase of MBP phosphorylation (Fig. 3A). For confirmation,
PKC-isoenzymes were immunoprecipitated from COS-cells
after cotransfection of HIV-Nef or mock DNA. Being a member
of the same PKC-subgroup (Liyanage et al., 1992), PKCε
served as control. As presented in Fig. 3B, the activity of PKCδ,
but not PKCε, increased in the presence of Nef 3–4-fold as
compared to mock transfection. The kinase activity was specific
for PKCδ, since a PKCδ protein with a mutated ATP binding
site (PKCδΔ) did not show any MBP phosphorylation. To
confirm that the N-terminus was involved in PKC activation, N-
terminal Nef fragments binding/not binding the NAKC (CN.35,
CN.15; Baur et al., 1997) were analyzed in a similar approach.
As presented in Fig. 3C, CN.35 but not CN.15 increased theactivity of PKCδ by about 4-fold. Therefore, association of the
N-terminus of Nef with PKCδ led to an increased activity of the
enzyme. Mutation of serine 6 did not influence binding of PKC
(Fig. 2B) and did not change the stimulating effects of Nef on
PKC (data not presented).
PKC kinase activity as well as Serine 6 are required for
Nef-supported HIV transcription
As demonstrated previously (Witte et al., 2004), Nef
increases transcription from the HIV promoter in the presence
of suboptimal levels of Tat. This was demonstrated in transient
transfection assays using J.CaM.1 cells and a HIV LTR
luciferase reporter construct. A deletion of the NAKC binding
site (Nef.Δ12–39) abolished this effect, implying that the
kinase complex was required. Therefore, we asked whether
PKC would modulate the positive Nef effects on transcription.
As demonstrated in Fig. 4A, coexpression of PKCδ (or PKCθ,
data not shown), but not of a different nPKC subfamily member
(PKCε), increased Tat-mediated transcription which was further
increased upon addition of Nef. Conversely, coexpression of a
Fig. 2. (A) Coexpression and immunoprecipitation of a panel of CD8-Nef deletion
mutants described previously (Wolf et al., 2001) with PKCθ in COS cells. The
immunoprecipitates (anti-CD8) were resolved by SDS-PAGE and blotted for PKCθ
association. (B) Nef.S6A associates with PKCθ. Coexpression and immunopreci-
pitation of full length Nef/Nef mutants with PKCθ in COS cells. The
immunoprecipitateswere resolved bySDS-PAGEandblotted for PKCθ association.
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of PKCε (PKCεΔ) greatly reduced the positive transcription
stimulus provided by Nef.Fig. 3. PKC activity increases in the presence of Nef. (A) Phosphorylation of myelin b
COS cells after cotransfection of Nef or mock DNA. (B) Phosphorylation of myelin b
mutated ATP binding site. The PKC isoenzymes were immunoprecipitated from CO
panel) was quantified by phosphor-imager which is presented in arbitrary units (lower
short CN-chimeras, binding (CN.35)/not binding (CN.15) the NAKC, into COS cells
quantified as described in panel B. For control, the lower panel shows binding of CNext, we asked whether the PKC recognition sequence was
also important for Nef-mediated transcription and employed our
transient assay to test the Nef.S6A mutant. Like Nef.Δ12–39
and non-myristoylated Nef.G2A, Nef.S6A failed to support
HIV transcription (Fig. 4B).
PKC kinase activity as well as Serine 6 is required for
Nef-supported HIV infectivity/replication
The impact of Nef on HIV replication in primary PBMC is
at least partly mirrored by its effect on virion infectivity in the
first round of infection (Fackler et al., 2006). Since the latter is
a function of the producer cell, we asked whether a
transdominant PKC mutant present during virus production
would reduce replication. HIV proviral DNA (NL4-3.SF2Nef)
was cotransfected with wild type - or ATP-binding mutants of
PKCδ and PKCε (PKCδΔ, PKCεΔ) into Jurkat cells to
produce virus particles. Resting PBMC were infected and, after
2 days, stimulated by addition of anti-CD3 antibodies. Culture
supernatants were monitored for RT-activity every second day
as shown for example in Fig. 5D. Infection with virions
produced in the presence of PKCδΔ resulted in a significant 2-
day delay of viral replication when compared to particles
produced in the presence of wild type PKCδ or PKCεΔ (Fig.asic protein (MBP) by endogenous PKCδ. PKCδ was immunoprecipitated from
asic protein (MBP) by transfected PKCε, PKCδ and PKCδΔ, the latter having a
S cells after cotransfection of Nef or mock DNA. Incorporation of 32P (upper
panel). (C) Phosphorylation of MBP by PKCε and PKCδ after cotransfection of
. For additional control, truncated CD8 (CT) was cotransfected. The results were
N.35 to PKCδ but not PKCε.
Fig. 4. Serine 6 is required for Nef-supported HIV transcription. (A) A kinase-inactive PKCδ mutant inhibits Nef-induced HIV transcription. Luciferase activity in
J.Cam.1 cells transfected with a HIV-LTR-Luciferase reporter (0.3 μg), Tat (0.05 μg), Lck (2 μg) and Nef (3,5 μg) along with PKCδ or ATP binding mutants of PKCδ
and PKCε (PKCδΔ, PKCεΔ) as indicated. Shown is the fold increase in transactivation (relative luciferase activity) over background (vector). (B) Same experimental
procedure as in panel A with cotransfection of Nef mutants as indicated and described in the text.
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replication took place in PHA-activated PBMC (Fig. 5B).
Likewise no difference was observed when virions were
produced in the presence of empty vector or PKCδ (Fig. 5DFig. 5. PKC modulates viral infectivity. Shown are representative of three experime
virions generated in the presence of PKCδ, or a kinase-defective mutant of PKCδ and
clone NL4-3.SF2Nef, which was cotransfected with the PKC isoenzymes into 293T c
infected (5 ng p24). After 2 days, cells were stimulated with OKT3 (α-CD3). Cultur
quantified by phospho-imager (phosphor-stimulated-luminescence or PSL-units). (B
supernatants described in panel A. (C) Same objective and procedure as in panel Awi
after a different transfection. (D) Inhibitory effects of kinase inactive PKCδ are Ne
negative mutant (NL4-3ΔNef) along with PKCδ/PKCδΔ as indicated. Infection and
infects/replicates poorly in resting PBMC, the viral inoculum was raised from 5 to
viruses: wild type (NL4-3.SF2Nef), Nef-negative (NL4-3ΔNef) and the S6A Nef mu
blot. Infection and monitoring were performed as described in panel A.and data not shown). To confirm these results, resting PBMC of
a second donor were infected with viral supernatants harvested
from a different DNA-transfection. Again, an almost identical
result was obtained (Fig. 5C).nts performed each. (A) HIV replication after infection of resting PBMC with
ε (PKCδΔ, PKCεΔ). Infectious viral supernatants were derived from the proviral
ells. The supernatants were normalized by p24 content and resting PBMC were
e supernatants were harvested every second day and assayed for RT-activity and
) HIV-replication after infection of PHA-activated PBMC using the same viral
th resting PBMC obtained from a different donor and viral supernatants obtained
f-dependent. Infection of resting PBMC with HIV (NL4-3.SF2Nef) and a Nef-
monitoring were performed as described in panel A. Since nef-negative strain
30 ng. (E) HIV replication after infection of resting PBMC with the following
tation (NL4-3.S6A). The insert shows expression of both Nef forms by Western
50 D. Wolf et al. / Virology 370 (2008) 45–54Next, we wanted to confirm that this effect was Nef-
dependent. A nef-negative proviral clone (NL4-3ΔNef) was
cotransfected with PKCδ or PKCδΔ. Viral supernatants were
obtained and resting PBMC were infected and analyzed as in
Figs. 5A and C. Since ΔNef strains infect/replicate in resting
PBMC poorly (Fig. 5D, lane 2; shown is the 32P incorporation
of the RT assay), the infectious dose was increased from 5 ng to
30 ng p24, which yielded a replication kinetic of the ΔNef
strain that was similar to HIV wild type (compare lanes 1 with
lanes 5 and 6). Under these conditions, PKCδ or PKCδΔ did
not affect the ability of the ΔNef virus to infect/replicate in
resting PBMC (Fig. 5D, compare lanes 5 and 6), whereas
coexpression of PKCδΔ caused a delayed replication with the
Nef-positive virus (lane 4), similar to the results shown in Figs.
5A and C. Thus, the effect of PKCδ on the infectivity/
replication potential of viral particles was Nef-dependent.
Collectively, these results demonstrated that the presence of
PKCδΔ changed the ability of HIV-virions to infect and repli-
cate in resting PBMC.
Next we assessed the role of the S6 PKC phosphorylation
site for infectivity/replication. The S6A mutation was intro-
duced into a proviral clone (NL4-3.SF2.S6A) and virus stocks
were generated. Resting PBMC were infected with this mutant
virus along with wild type (NL4-3.SF2.Nef) and ΔNef (NL4-
3ΔNef) controls similar to those described in Figs. 5A–D. Both
NL4-3ΔNef as well as NL4-3.SF2.S6A showed a significant
delay of viral replication as compared to the wild type control
(Fig. 5E). Thus, the integrity of the PKC phosphorylation site in
Nef appeared to be important for optimal HIV replication in
human PBMC.
Serine 6 affects myristoylation-associated Nef functions and its
subcellular localization
In order to explain the defects seen in transcription and
infectivity, we asked whether serine 6 was required for well
established Nef functions like CD4-downmodulation and
association with Pak2 activity. First, however, we analyzed theFig. 6. Serine 6 is not required for myristoylation-associated functions but influence
proteins in 293Tcells. Autoradiographs of anti-GFP immunoprecipitate from 293Tce
3H myristic acid (upper panel) or 35S Met/Cys (lower panel), respectively. (B) Pak2 a
IVKA in anti-GFP immunoprecipitates from Jurkat cells expressing the indicated prot
used for IVKA analysis. (C) CD4 downregulation activity of Nef S6A. Steady-state
proteins assessed by flow cytometry (upper panel). Shown is the relative CD4 down
The lower panel depicts an anti-GFP Western blot of the cells used for FACS analyimportance of serine 6 for Nef myristoylation which is thought to
be vital for this cotranslational modification. Metabolic labeling
with 3H myristic acid (Fig. 6A, upper panel) or 35S methionine/
cysteine (lower panel) revealed efficient myristoylation of the
S6A mutant, although the reaction was reduced when compared
with wild type Nef.GFP. As expected, the Nef mutant lacking the
myristoyl acceptor glycine at position 2 (G2A) was not
myristoylated. To mimic phosphorylation at position 6, the
respective serine was mutated to glutamic acid (S6E). However,
this change completely prevented myristoylation of Nef.
In accordance with the myristoylation results, the analysis of
Nef-associated Pak2 activity by IVKA revealed a slight
reduction of autophosphorylated Pak2 levels associated with
S6A as compared to wild type Nef (Fig. 6B). For this analysis,
Nef.GFP fusion proteins were transiently transfected into Jurkat
cells. When steady-state cell surface levels of CD4 were
investigated by flow cytometry, Nef.S6A and wild type Nef
were equally efficient in downmodulating CD4 surface pre-
sentation (Fig. 6C). In contrast, Nef.G2Awas severely impaired
in this assay. Taken together, these two Nef functions did not
correlate with the replication/infectivity defects seen above.
Since some Nef activities require the association of Nef with
lipid rafts (Krautkramer et al., 2004; Giese et al., 2006), we
assessed the presence of the Nef.S6A mutant in this
subcompartment (Fig. 7A) by a raft flotation analysis. The
latter was performed with lysates of Jurkat cells transiently
transfected with Nef.GFP fusion proteins. As in previous
reports (Krautkramer et al., 2004; Sol-Foulon et al., 2004; Wang
et al., 2000), a subpopulation of Nef but not Nef.G2Awas found
enriched in the lipid raft fraction. Nef.S6A had an intermediate
phenotype in this assay, showing significant but reduced
incorporation in the raft fraction.
In the same transfected cells, the subcellular localization was
analyzed by confocal microscopy. Lipid rafts at the plasma
membrane were visualized by clustering with Alexa 594
conjugated cholera toxin B (CTx) and anti-CTx antibody. As
expected, Nef was found at the plasma membrane colocalizing
with clusters stained by CTx (Fig. 7C, panels B, C). Typically as the subcellular localization of Nef. (A) Metabolic labeling of Nef.GFP fusion
lls expressing the indicated Nef.GFP fusion proteins after metabolic labeling with
ctivity is associated with Nef S6A. Nef-associated Pak2 activity was analyzed by
eins (upper panel). The lower panel depicts an anti-GFPWestern blot of the cells
surface levels of CD4 of SupT1 cells expressing the indicated GFP or Nef.GFP
regulation in comparison to Nef.GFP (100%) in three independent experiments.
sis.
Fig. 7. (A) Lipid raft flotation analysis from Jurkat cells expressing the indicated Nef.GFP fusion proteins. Cell lysates (1% TX-100) were separated by
ultracentrifugation and eight fractions were collected and subjected to anti-GFPWestern Blotting. (B) Control Western Blots of raft flotations using fraction 2 as raft (r)
and pooled fractions 7 and 8 as non-raft (nr) fractions. Transferrin receptor (Tfr) serves as non-raft marker, while LAT is partially recruited into raft microdomains and
serves as marker of r fractions. (C) Confocal analysis of Nef.GFP in Cholera toxin (CTx) positive membrane microdomains. Jurkat cells expressing the indicated Nef.
GFP fusion proteins (panels A–C) were subjected to raft clustering by incubation with Alexa 594-conjugated CTx and subsequent cross linking with anti-CTx. The
merge panel depicts the overlay of Alexa and GFP fluorescence channels. The arrow depicts Nef accumulated at perinuclear membranes. Presented are single
representative sections. (D) Quantification of the subcellular localization of Nef.GFP in Jurkat as depicted in panel C.
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(Fig. 7C, panel A, see red arrow). In contrast, the S6A mutant
displayed a different phenotype. While still present in raft
clusters at the plasma membrane, we did not observe a peri-
nuclear accumulation but rather a diffuse cytoplasmic distribu-
tion similar to that seen for G2A (Fig. 7C, panels D, G).
Consistent with its complete lack of myristoylation, the S6E
mutant revealed the same subcellular localization as Nef.G2A at
the plasma membrane and in the cytoplasm (for quantification
of Nef's subcellular localization see Fig. 7D). Thus, the serine at
position 6 seemed to be critically involved in Nef's subcellular
distribution.
Discussion
In this study we set out to identify the Nef-phosphorylating
serine kinase of the Nef-associated kinase complex (NAKC)
and analyze its functional relevance for HIV-1 Nef. Serine 6 was
identified as a phosphorylation site within a PKC consensussequence which led to the identification of the nPKC family
members as Nef-interacting kinases.
Phosphorylation of HIV-1 Nef is a long standing observation
(Bandres et al., 1994; Coates and Harris, 1995; Guy et al., 1987;
Li et al., 2005) and several reports suggested that this might
involve binding (Smith et al., 1996) and serine phosphorylation
by PKC (Bodeus et al., 1995; Coates et al., 1997; Luo et al.,
1997). While other isoforms of the PKC family clearly failed to
phosphorylate Nef, we were unable to distinguish between
PKCδ and θ as the preferred PKC binding partner of Nef. This
most likely reflects the high homology between both kinases
(62.5% amino acid identity), that form one closely related
subgroup of the nPKC subfamily (Baier, 2003). This homology
along with the unavailability of specific pharmacological
inhibitors precluded further in depth analysis. While PKCθ is
almost exclusively found in T cells, PKCδ is ubiquitously
expressed. Thus, both kinases could account for the phosphor-
ylation of Nef in T cells. The role of PKCθ in TCR signal
transduction is well established (Isakov and Altman, 2002) and
52 D. Wolf et al. / Virology 370 (2008) 45–54given the fact that Nef interacts with the TCR environment,
PKCθ seems to be a likely interactor. Moreover, Nef was
reported to associate with PKCθ in Jurkat cells, in which PKCδ
was not detectable by Western blotting (Smith et al., 1996).
However, we have recently identified an additional adaptor
protein in the NAKC (data not shown) which is a known
interactor of PKCδ. Notably this adaptor protein attracts
additional components involved in the activation of PKC,
which would explain the here presented results showing the
increased activity of PKC through Nef. Taken together, it is
possible that Nef expression affects the function and activity of
both nPKCs, which, in a second step, would lead to the
phosphorylation of Nef and potentially more effectors. Whether
phosphorylation of Nef is mediated by PKCθ or δ might also
depend on their relative expression levels in a given cell. PKCδ
then could account for the phosphorylation of Nef in non-T cells
lacking PKCθ(Coates et al., 1997; Coates and Harris, 1995).
A key result in our analysis was the relevance of PKC and its
recognition site serine 6 for positive Nef effects on HIV
transcription and virus replication in primary PBMC. The latter
prompted us to look for mechanistic explanations. Phosphor-
ylation of Nef could have been a key step in modulating the
conformation and/or interaction capacity of the protein as
suggested previously (Arold and Baur, 2001). However, while
we found evidence for reduced binding of interacting proteins
(e.g. Lck, Eed, PI3 kinase) to Nef.S6A (data not shown), these
effects were moderate and could have been attributed to the
slightly reduced myristoylation of S6A. PKCs are well-known
modulators of protein–membrane interactions that trigger
electrostatic switches by phosphorylation of myristoylated
proteins that usually detach from membranes as a consequence
(McLaughlin and Aderem, 1995). Therefore mutation of serine
6 may have increased membrane and raft association of Nef.
However, taking into account that myristoylation of Nef.S6A
was less efficient, its association with membranes and rafts was
comparable to wild type Nef (Figs. 7A and C). Interestingly,
however, we found that the subcellular localization of Nef.S6A
was significantly altered. Usually Nef accumulates in endoso-
mal compartments of the perinuclear region (Stumptner-
Cuvelette et al., 2003; Thoulouze et al., 2006; Witte et al.,
2004). Conversely, Nef.S6A showed the same diffuse cyto-
plasmic distribution as the G2A and S6E Nef variants. It is
therefore possible that phosphorylation of serine 6, potentially
occurring at the plasma membrane, serves as a routing signal for
Nef in the course of its subsequent internalization. Our data
would further suggest that this function is relevant for the
positive effects of Nef on HIV transcription/replication.
Unraveling the meaning of the perinuclear targeting of Nef
may provide interesting new insights into the overall function
and mechanism of this enigmatic protein.
Materials and methods
Plasmid constructions
The CD8-Nef (SF2) fusion proteins as well as mutations in
the nef-gene were generated by a two step PCR procedure andcloned into the pRcCMVexpression vector (pCN) as described
previously (Baur et al., 1997, 1994). Resulting constructs were
designated pCN (for CD8-Nef) plus the number of amino acids
fused to CD8 (for example pCN.35). Expression constructs for
wt and most mutant Nef.GFP fusion proteins as well as the N-
terminal Nef fragments fused to GFP were described earlier
(Giese et al., 2006; Haller et al., 2006). Expression constructs
for the S6A and S6E Nef.GFP variants were generated by
subcloning of the respective nef-PCR amplicons in frame with
the gfp open reading into the pEGFP-N1 vector (Invitrogen,
Carlsbad, CA). Cloning and characterization of the PKC
expression plasmids have been described previously (Freise-
winkel et al., 1991; Liyanage et al., 1992). The human
homologues of PKCθ and δ were obtained from G. Baier,
Innsbruck, Austria. A HA-tag (CYPYDVPDYASL) was added
to the C-terminus of PKCθ and δ by PCR. Both genes were
subsequently cloned into the pCR3 (Invitrogen) and pEF-BOS
vector (Mizushima and Nagata, 1990). Construction of the
proviral clone NL4-3, containing the SF2 nef-gene (NL4-3.SF2.
Nef), the S6A mutant (NL4-3.SF2.S6A) and the Nef-negative
construct (NL4-3ΔNef), was described previously (Baur et al.,
1997). All chimeric constructs and mutations were verified by
dideoxynucleotide sequencing. The HIV-LTR reporter construct
contained the entire HIV LTR upstream of a luciferase reporter
gene and was used previously (Witte et al., 2004).
Cells, antibodies and recombinant proteins
PBMC were obtained from healthy donors and separated by
Ficoll gradient as described previously (Geffin et al., 2000).
Jurkat cells were grown in RPMI 1640 medium/10% FCS.
Jurkat cell lines constitutively expressing truncated CD8 or
CD8-Nef fusion proteins (SF2) were cultured in RPMI 1640
medium/10% fetal calf serum (FCS)/Geneticin at 500 mg/ml
(G418, Invitrogen). COS-7 and 293T cells were grown in
Dulbecco's minimal essential medium (DMEM) containing
10% FCS. The anti-CD8 monoclonal antibody OKT8, obtained
from American Type Culture Collection, recognizes an
extracellular epitope of CD8 and was used at a concentration
of 1 μg/ml. The rabbit anti-SF2 Nef serum, raised against
recombinant SF2-Nef protein, was kindly provided by Patricia
Olson, Chiron Corp (Emeryville, CA) and used at a 1:500
dilution. Polyclonal rabbit serum against GFP was a kind gift of
Hans-Georg Kräusslich. The mAb against the AU-1-epitope
was purchased from Hiss-Diagnostics (Freiburg, Germany).
Alexa 594-conjugated CTx was from Molecular Probes
(Leiden, Netherlands), as well as all secondary fluorescent
antibodies. The PE-conjugated anti-CD4 antibody Leu3a was
from Pharmingen (Heidelberg, Germany). The polyclonal
rabbit anti-CTx serum was from Sigma (Munich, Germany).
The anti-Lck mouse monoclonal antibody 3A5 was from Santa
Cruz Biotechnology (Heidelberg, Germany).
Protein expression assays
Transfections into T and COS cells, metabolic labeling with
35S-Translabel, immunoprecipitation, Western blot and in vitro
53D. Wolf et al. / Virology 370 (2008) 45–54kinase assays were performed as described previously (Baur et
al., 1997, 1994; Krautkramer et al., 2004). In selected assays
(Fig. 1D), the kinase inhibitors H7 (Sigma, 150 mmol) and
Staurosporine (5 mg/ml) were added to the kinase reaction. The
cells were lysed (EB or extraction buffer: 1% NP-40, 150 mM
NaCl and 50 mM Tris–HCl (pH 8)) in the presence of protease
inhibitors phenylmethylsulfonyl fluoride (PMSF, 1 mM),
leupeptin (10 μg/ml) and aprotinin (500 U/ml). The immuno-
precipitates were washed three times (WB or wash buffer: 1%
NP-40, 450 mM NaCl, 50 mM Tris–HCl (pH 8), 1 mM EDTA).
Prior to the in vitro kinase assays, the immunoprecipitates were
washed once with the kinase activation buffer (KAB: 50 mM
HEPES (pH 8.0)/150 mM NaCl/5 mM EDTA/0.02% Triton X-
100 and 10 mM MnCl2 or MgCl2). Unless indicated in the
figure legends, Mn2+ cations were used in the KAB.
Virus stocks, viral replication and transcription assays
2×106 Jurkat and SupT1 cells were transfected by electro-
poration with 20 μg of linearized proviral DNA. After 7 days of
culture, supernatants were assayed for RT-activity. All proviral
clones used yielded comparable RT-values in the culture
supernatant, which were subsequently filtered and assayed/
standardized for p24 antigen concentration. For infection of
resting PBMC, 2×106 PBMC from an adult donor were
infected, in duplicates, with 2 ng p24 of wild type and mutant
viruses. The infected cells were then cultured for 2 days and
subsequently stimulated for 2 days with OKT3 (anti CD3) at a
concentration of 0.2 μg/ml. Thereafter the cells were washed
and culture supernatants were collected every second day for 2
weeks and subsequently tested for RT-activity in 10 μl of
supernatant. For the luciferase reporter assays, 2×106 J.CaM1
cells were transfected as indicated and harvested 16 h later. The
luciferase activity was measured using the Luciferase Assay
System with Reporter Lysis Buffer (Promega, Mannheim,
Germany) according to the manufacturer's instructions.
Functional analysis of Nef.GFP fusion proteins
IVKA for Nef.GFP-associated Pak2 activity, raft flotation
and raft clustering experiments including confocal microcopy
were performed as described recently (Krautkramer et al.,
2004). CD4 downregulation by Nef was measured in electro-
porated SupT1 cells by quantification of the steady-state cell
surface CD4 levels by Fluorescence-activated cell sorting
(FACS) using phycoerythrin (PE)-conjugated anti-human
CD4. Samples were collected on a FACSCalibur or FACScan
flow cytometer (Becton Dickinson, Heidelberg, Germany) and
analyzed with Cellquest software, comparing the CD4 levels of
GFP positive, live lymphocytes. Myristoylation was analyzed in
80% confluent 6 well plates of 293T cells expressing Nef.GFP
fusion proteins that were serum starved for 1 h at 24 h post
transfection. Following PBS washing, the cells were metabo-
lically labeled with 50 μCi 35S in vitro cell labeling Pro mix
(Amersham Biosciences, Freiburg, Germany) or 150 μCi [3H]
myristic acid (Amersham) for 4 h. Following the labeling
period, cells were washed in PBS and lysed in RIPA buffer(150 mM NaCl, 50 mM Tris–HCl pH 7.2, 1% Triton X-100,
0.1% SDS and protease inhibitors) and cleared lysates were
subjected to anti-GFP immunoprecipitation. After SDS-PAGE
of the immunoprecipitates, gels were fixed and enhanced using
Amplify (Amersham) and exposed for 24 h (35S) and 6 weeks
(3H), respectively, for autoradiography.
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